Selected research
Market Outlook & Growth Opportunities
Global Hormones Test Service Market Outlook and Growth Opportunities 2026
Market perspective
The global Hormones Test Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Hormones Test Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Hormones Test Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Hormones Test Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Hormones Test Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Hormones Test Service market include MP Biomedicals, Randox, Forth, Quest, Thriva, Testing, LetsGet Checked, Medichecks and iMEDICAL, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Hormones Test Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Hormones Test Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Hormones Test Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Hormones Test Service market.
Hormones Test Service Segment by Company
MP Biomedicals
Randox
Forth
Quest
Thriva
Testing
LetsGet Checked
Medichecks
iMEDICAL
Lab Me
Veracity
Goodbody
Balance My Hormones
Genova
Hipro Biotechnology
Hormones Test Service Segment by Type
Blood Test
Saliva Test
Hormones Test Service Segment by Application
Female
Male
Hormones Test Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Hormones Test Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Hormones Test Service key companies, revenue, market share, and recent developments.
3. To split the Hormones Test Service breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Hormones Test Service market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Hormones Test Service significant trends, drivers, influence factors in global and regions.
6. To analyze Hormones Test Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hormones Test Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hormones Test Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hormones Test Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Hormones Test Service industry.
Chapter 3: Detailed analysis of Hormones Test Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Hormones Test Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Hormones Test Service in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Blood Test
- Saliva Test
Applications
- Female
- Male
Companies covered
- MP Biomedicals
- Randox
- Forth
- Quest
- Thriva
- Testing
- LetsGet Checked
- Medichecks
- iMEDICAL
- Lab Me
- Veracity
- Goodbody
- Balance My Hormones
- Genova
- Hipro Biotechnology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Hormones Test Service Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Hormones Test Service Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Hormones Test Service Market Dynamics
- 2.1 Hormones Test Service Industry Trends
- 2.2 Hormones Test Service Industry Drivers
- 2.3 Hormones Test Service Industry Opportunities and Challenges
- 2.4 Hormones Test Service Industry Restraints
3 Hormones Test Service Market by Company
- 3.1 Global Hormones Test Service Company Revenue Ranking in 2025
- 3.2 Global Hormones Test Service Revenue by Company (2021-2026)
- 3.3 Global Hormones Test Service Company Ranking (2024-2026)
- 3.4 Global Hormones Test Service Company Manufacturing Base and Headquarters
- 3.5 Global Hormones Test Service Company Product Type and Application
- 3.6 Global Hormones Test Service Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Hormones Test Service Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Hormones Test Service Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Hormones Test Service Market by Type
- 4.1 Hormones Test Service Type Introduction
- 4.1.1 Blood Test
- 4.1.2 Saliva Test
- 4.2 Global Hormones Test Service Sales Value by Type
- 4.2.1 Global Hormones Test Service Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Hormones Test Service Sales Value by Type (2021-2032)
- 4.2.3 Global Hormones Test Service Sales Value Share by Type (2021-2032)
5 Hormones Test Service Market by Application
- 5.1 Hormones Test Service Application Introduction
- 5.1.1 Female
- 5.1.2 Male
- 5.2 Global Hormones Test Service Sales Value by Application
- 5.2.1 Global Hormones Test Service Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Hormones Test Service Sales Value by Application (2021-2032)
- 5.2.3 Global Hormones Test Service Sales Value Share by Application (2021-2032)
6 Hormones Test Service Regional Value Analysis
- 6.1 Global Hormones Test Service Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Hormones Test Service Sales Value by Region (2021-2032)
- 6.2.1 Global Hormones Test Service Sales Value by Region: 2021-2026
- 6.2.2 Global Hormones Test Service Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Hormones Test Service Sales Value (2021-2032)
- 6.3.2 North America Hormones Test Service Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Hormones Test Service Sales Value (2021-2032)
- 6.4.2 Europe Hormones Test Service Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Hormones Test Service Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Hormones Test Service Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Hormones Test Service Sales Value (2021-2032)
- 6.6.2 South America Hormones Test Service Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Hormones Test Service Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Hormones Test Service Sales Value Share by Country, 2025 VS 2032
7 Hormones Test Service Country-level Value Analysis
- 7.1 Global Hormones Test Service Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Hormones Test Service Sales Value by Country (2021-2032)
- 7.2.1 Global Hormones Test Service Sales Value by Country (2021-2026)
- 7.2.2 Global Hormones Test Service Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Hormones Test Service Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Hormones Test Service Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Hormones Test Service Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Hormones Test Service Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Hormones Test Service Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Hormones Test Service Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Hormones Test Service Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Hormones Test Service Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Hormones Test Service Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Hormones Test Service Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Hormones Test Service Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Hormones Test Service Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Hormones Test Service Sales Value Growth Rate (2021-2032)
- 7.7.2 France Hormones Test Service Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Hormones Test Service Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Hormones Test Service Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Hormones Test Service Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Hormones Test Service Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Hormones Test Service Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Hormones Test Service Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Hormones Test Service Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Hormones Test Service Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Hormones Test Service Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Hormones Test Service Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Hormones Test Service Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Hormones Test Service Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Hormones Test Service Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Hormones Test Service Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Hormones Test Service Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Hormones Test Service Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Hormones Test Service Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Hormones Test Service Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Hormones Test Service Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Hormones Test Service Sales Value Growth Rate (2021-2032)
- 7.14.2 China Hormones Test Service Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Hormones Test Service Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Hormones Test Service Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Hormones Test Service Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Hormones Test Service Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Hormones Test Service Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Hormones Test Service Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Hormones Test Service Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Hormones Test Service Sales Value Growth Rate (2021-2032)
- 7.17.2 India Hormones Test Service Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Hormones Test Service Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Hormones Test Service Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Hormones Test Service Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Hormones Test Service Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Hormones Test Service Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Hormones Test Service Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Hormones Test Service Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Hormones Test Service Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Hormones Test Service Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Hormones Test Service Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Hormones Test Service Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Hormones Test Service Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Hormones Test Service Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Hormones Test Service Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Hormones Test Service Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Hormones Test Service Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Hormones Test Service Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Hormones Test Service Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Hormones Test Service Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Hormones Test Service Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Hormones Test Service Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Hormones Test Service Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Hormones Test Service Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Hormones Test Service Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Hormones Test Service Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Hormones Test Service Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Hormones Test Service Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Hormones Test Service Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Hormones Test Service Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Hormones Test Service Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Hormones Test Service Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Hormones Test Service Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Hormones Test Service Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Hormones Test Service Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Hormones Test Service Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Hormones Test Service Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Hormones Test Service Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Hormones Test Service Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Hormones Test Service Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Hormones Test Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 MP Biomedicals
- 8.1.1 MP Biomedicals Company Information
- 8.1.2 MP Biomedicals Business Overview
- 8.1.3 MP Biomedicals Hormones Test Service Revenue and Gross Margin (2021-2026)
- 8.1.4 MP Biomedicals Hormones Test Service Product Portfolio
- 8.1.5 MP Biomedicals Recent Developments
- 8.2 Randox
- 8.2.1 Randox Company Information
- 8.2.2 Randox Business Overview
- 8.2.3 Randox Hormones Test Service Revenue and Gross Margin (2021-2026)
- 8.2.4 Randox Hormones Test Service Product Portfolio
- 8.2.5 Randox Recent Developments
- 8.3 Forth
- 8.3.1 Forth Company Information
- 8.3.2 Forth Business Overview
- 8.3.3 Forth Hormones Test Service Revenue and Gross Margin (2021-2026)
- 8.3.4 Forth Hormones Test Service Product Portfolio
- 8.3.5 Forth Recent Developments
- 8.4 Quest
- 8.4.1 Quest Company Information
- 8.4.2 Quest Business Overview
- 8.4.3 Quest Hormones Test Service Revenue and Gross Margin (2021-2026)
- 8.4.4 Quest Hormones Test Service Product Portfolio
- 8.4.5 Quest Recent Developments
- 8.5 Thriva
- 8.5.1 Thriva Company Information
- 8.5.2 Thriva Business Overview
- 8.5.3 Thriva Hormones Test Service Revenue and Gross Margin (2021-2026)
- 8.5.4 Thriva Hormones Test Service Product Portfolio
- 8.5.5 Thriva Recent Developments
- 8.6 Testing
- 8.6.1 Testing Company Information
- 8.6.2 Testing Business Overview
- 8.6.3 Testing Hormones Test Service Revenue and Gross Margin (2021-2026)
- 8.6.4 Testing Hormones Test Service Product Portfolio
- 8.6.5 Testing Recent Developments
- 8.7 LetsGet Checked
- 8.7.1 LetsGet Checked Company Information
- 8.7.2 LetsGet Checked Business Overview
- 8.7.3 LetsGet Checked Hormones Test Service Revenue and Gross Margin (2021-2026)
- 8.7.4 LetsGet Checked Hormones Test Service Product Portfolio
- 8.7.5 LetsGet Checked Recent Developments
- 8.8 Medichecks
- 8.8.1 Medichecks Company Information
- 8.8.2 Medichecks Business Overview
- 8.8.3 Medichecks Hormones Test Service Revenue and Gross Margin (2021-2026)
- 8.8.4 Medichecks Hormones Test Service Product Portfolio
- 8.8.5 Medichecks Recent Developments
- 8.9 iMEDICAL
- 8.9.1 iMEDICAL Company Information
- 8.9.2 iMEDICAL Business Overview
- 8.9.3 iMEDICAL Hormones Test Service Revenue and Gross Margin (2021-2026)
- 8.9.4 iMEDICAL Hormones Test Service Product Portfolio
- 8.9.5 iMEDICAL Recent Developments
- 8.10 Lab Me
- 8.10.1 Lab Me Company Information
- 8.10.2 Lab Me Business Overview
- 8.10.3 Lab Me Hormones Test Service Revenue and Gross Margin (2021-2026)
- 8.10.4 Lab Me Hormones Test Service Product Portfolio
- 8.10.5 Lab Me Recent Developments
- 8.11 Veracity
- 8.11.1 Veracity Company Information
- 8.11.2 Veracity Business Overview
- 8.11.3 Veracity Hormones Test Service Revenue and Gross Margin (2021-2026)
- 8.11.4 Veracity Hormones Test Service Product Portfolio
- 8.11.5 Veracity Recent Developments
- 8.12 Goodbody
- 8.12.1 Goodbody Company Information
- 8.12.2 Goodbody Business Overview
- 8.12.3 Goodbody Hormones Test Service Revenue and Gross Margin (2021-2026)
- 8.12.4 Goodbody Hormones Test Service Product Portfolio
- 8.12.5 Goodbody Recent Developments
- 8.13 Balance My Hormones
- 8.13.1 Balance My Hormones Company Information
- 8.13.2 Balance My Hormones Business Overview
- 8.13.3 Balance My Hormones Hormones Test Service Revenue and Gross Margin (2021-2026)
- 8.13.4 Balance My Hormones Hormones Test Service Product Portfolio
- 8.13.5 Balance My Hormones Recent Developments
- 8.14 Genova
- 8.14.1 Genova Company Information
- 8.14.2 Genova Business Overview
- 8.14.3 Genova Hormones Test Service Revenue and Gross Margin (2021-2026)
- 8.14.4 Genova Hormones Test Service Product Portfolio
- 8.14.5 Genova Recent Developments
- 8.15 Hipro Biotechnology
- 8.15.1 Hipro Biotechnology Company Information
- 8.15.2 Hipro Biotechnology Business Overview
- 8.15.3 Hipro Biotechnology Hormones Test Service Revenue and Gross Margin (2021-2026)
- 8.15.4 Hipro Biotechnology Hormones Test Service Product Portfolio
- 8.15.5 Hipro Biotechnology Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst